These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25877475)

  • 21. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.
    Fiege B; Blau N
    J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum to "Next generation sequencing of patients with mut methylmalonic aciduria: Validation of somatic cell studies and identification of 16 novel mutations." [Mol. Genet. Metab. (Aug 2016); 118(4): 264-71].
    Chu J; Pupavac M; Watkins D; Tian X; Feng Y; Chen S; Fenter R; Zhang VW; Wang J; Wong LJ; Rosenblatt DS
    Mol Genet Metab; 2017 Mar; 120(3):295. PubMed ID: 28284539
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Development of hypomelanotic macules is associated with constitutive activated mTORC1 in tuberous sclerosis complex" [Mol. Genet. Metab. 120(4) (Apr 2017) 384-391].
    Møller LB; Schönewolf-Greulich B; Rosengren T; Larsen LJ; Ostergaard JR; Sommerlund M; Ostenfeldt C; Stausbøl-Grøn B; Linnet KM; Gregersen PA; Jensen UB
    Mol Genet Metab; 2018 Dec; 125(4):361. PubMed ID: 29325814
    [No Abstract]   [Full Text] [Related]  

  • 24. Adherence to tetrahydrobiopterin therapy in patients with phenylketonuria.
    Rohr F; Wessel A; Brown M; Charette K; Levy HL
    Mol Genet Metab; 2015 Jan; 114(1):25-8. PubMed ID: 25467057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo studies of phenylalanine hydroxylase by phenylalanine breath test: diagnosis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Okano Y; Hase Y; Kawajiri M; Nishi Y; Inui K; Sakai N; Tanaka Y; Takatori K; Kajiwara M; Yamano T
    Pediatr Res; 2004 Nov; 56(5):714-9. PubMed ID: 15319459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227].
    Wang RY; da Silva Franco JF; López-Valdez J; Martins E; Sutton VR; Whitley CB; Zhang L; Cimms T; Marsden D; Jurecka A; Harmatz P
    Mol Genet Metab; 2020; 131(1-2):285. PubMed ID: 32843286
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterin.
    Vilaseca MA; Lambruschini N; Gómez-López L; Gutiérrez A; Moreno J; Tondo M; Artuch R; Campistol J
    Clin Biochem; 2010 Mar; 43(4-5):411-5. PubMed ID: 19948162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum to "Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.·Arg116gln) mutation" [Mol. Genet. Metab. 122/1-2 (2017) 135-142].
    di Salvo ML; Mastrangelo M; Nogués I; Tolve M; Paiardini A; Carducci C; Mei D; Montomoli M; Tramonti A; Guerrini R; Contestabile R; Leuzzi V
    Mol Genet Metab; 2018 Dec; 125(4):359. PubMed ID: 29548777
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular characterization of phenylketonuria and tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Japan.
    Okano Y; Kudo S; Nishi Y; Sakaguchi T; Aso K
    J Hum Genet; 2011 Apr; 56(4):306-12. PubMed ID: 21307867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes.
    Cleary M; Trefz F; Muntau AC; Feillet F; van Spronsen FJ; Burlina A; Bélanger-Quintana A; Giżewska M; Gasteyger C; Bettiol E; Blau N; MacDonald A
    Mol Genet Metab; 2013 Dec; 110(4):418-23. PubMed ID: 24090706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum to "A systematic cross-sectional survey of multiple sulfatase deficiency" [Mol Genet Metab. 2020 Aug;130(4):283-288].
    Cappuccio G; Alagia M; Brunetti-Pierri N
    Mol Genet Metab; 2020; 131(1-2):284. PubMed ID: 33144036
    [No Abstract]   [Full Text] [Related]  

  • 33. Maternal phenylketonuria: a metabolic teratogen.
    Levy HL; Ghavami M
    Teratology; 1996 Mar; 53(3):176-84. PubMed ID: 8761885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylalanine hydroxylase: function, structure, and regulation.
    Flydal MI; Martinez A
    IUBMB Life; 2013 Apr; 65(4):341-9. PubMed ID: 23457044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum to "Retinal thinning in Gaucher disease patients and carriers: Results of a pilot study" [Mol. Genet. Metab. 109 (2013) 221-223].
    McNeill A; Roberti G; Lascaratos G; Hughes D; Mehta A; Garway-Heath DF; Schapira AHV
    Mol Genet Metab; 2014 Mar; 111(3):408. PubMed ID: 28843379
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene.
    Shintaku H; Kure S; Ohura T; Okano Y; Ohwada M; Sugiyama N; Sakura N; Yoshida I; Yoshino M; Matsubara Y; Suzuki K; Aoki K; Kitagawa T
    Pediatr Res; 2004 Mar; 55(3):425-30. PubMed ID: 14681498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Blau N; Erlandsen H
    Mol Genet Metab; 2004 Jun; 82(2):101-11. PubMed ID: 15171997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum to "Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook" [Mol Genet Metab. 2019 May;127(1):12-22].
    Himmelreich N; Montioli R; Bertoldi M; Carducci C; Leuzzi V; Gemperle C; Berner T; Hyland K; Thöny B; Hoffmann GF; Voltattorni CB; Blau N
    Mol Genet Metab; 2021; 134(1-2):216. PubMed ID: 34244047
    [No Abstract]   [Full Text] [Related]  

  • 40. Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias.
    Blau N
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1207-18. PubMed ID: 23705856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.